Anxiety and depression often occur together. When they do, symptoms can overlap and interact, affecting everything from your energy and motivation to sleep, concentration, relationships and daily life.
If you are experiencing both, you may wonder whether treatment has to address them separately or whether one treatment plan can account for your full symptom picture.
TMS therapy may be considered for certain patients experiencing depression with co-occurring anxiety symptoms.
At Neurotherapeutix, treatment planning looks beyond diagnosis alone. We use functional brain imaging and computational analysis to understand connectivity patterns in your individual brain and determine how to personalize treatment to your symptoms.
Learn more about TMS therapy for depression and our approach to TMS therapy for anxiety.
Quick answer: Can TMS therapy treat co-occurring anxiety and depression?
TMS therapy may help some people who experience depression along with anxiety symptoms.
Rather than assuming the two conditions should be treated identically, your clinical team can evaluate your full symptom profile and determine which brain networks and treatment targets are most relevant.
At Neurotherapeutix, fMRI-guided TMS treatment allows that planning to reflect your individual functional brain organization rather than relying only on a standard treatment location.
Treatment response varies, and improvement in depression does not guarantee the same degree or timing of improvement in anxiety.
How common are co-occurring anxiety and depression?
Depression and anxiety are distinct conditions, but they frequently occur together.
Someone experiencing depression may also have persistent worry, tension, restlessness or fear. A person primarily seeking help for anxiety may also experience low mood, loss of interest, fatigue or feelings of hopelessness.
The National Institute of Mental Health notes that anxiety disorders can occur alongside depression and other mental health conditions. This overlap is one reason a comprehensive evaluation matters.
Having both conditions does not necessarily mean they have the same cause or involve exactly the same areas of the brain. Mental health conditions are complex, and symptom patterns can differ substantially from one person to another.
For treatment planning, the more important question is not simply: Which diagnoses do you have? It is: What does your individual symptom presentation and brain function tell us about how treatment should be approached?
How TMS therapy addresses co-occurring symptoms
Transcranial magnetic stimulation (TMS) uses magnetic pulses to influence activity within targeted areas of the brain and connected networks.
TMS is an established treatment for major depressive disorder, including for certain patients whose symptoms have not adequately improved with other treatments.
That does not mean depression and anxiety are interchangeable or that there is one universal brain target responsible for both.
Mood regulation, emotional processing, attention, and responses to stress involve interconnected brain networks. The way those networks function can vary among patients, even when they share the same diagnoses.
At Neurotherapeutix, fMRI-guided TMS therapy is designed around that individual variability.
Instead of beginning with the assumption that every person with depression, anxiety, or both should receive stimulation in essentially the same location, we first examine how functional networks throughout your brain are communicating.
That information can then help inform an individualized treatment plan based on your brain activity, symptoms and clinical history.
Why computational brain mapping matters when symptoms overlap
Two people can both be diagnosed with anxiety and depression and still experience those conditions very differently.
One person may struggle primarily with low mood, loss of motivation and persistent worry. Another may experience physical tension, difficulty sleeping, racing thoughts and an inability to enjoy activities they once valued.
Their diagnoses may look similar on paper, but their functional brain connectivity may not.
That is where computational brain mapping becomes particularly useful.
At Neurotherapeutix, your evaluation begins with resting-state functional magnetic resonance imaging (rsfMRI). Unlike a standard structural MRI, which primarily shows brain anatomy, rsfMRI measures patterns of activity and communication among functional brain networks while you are at rest.
Our patented computational technology analyzes those connectivity patterns to identify individualized areas of interest based on your functional brain organization.
The fMRI analysis identifies individualized treatment targets within the patient’s own brain anatomy. These selected target regions are then uploaded into the neuronavigation system, allowing the clinical team to consistently position the TMS coil over the intended anatomical tissue with millimeter-level precision throughout treatment..
For someone experiencing overlapping symptoms, this whole-brain approach provides information that diagnosis alone cannot: a view of how your functional brain networks are organized.
It does not guarantee that TMS therapy will improve both anxiety and depression. Instead, it allows treatment planning to be informed by individual brain function rather than relying only on standardized targeting.
What treatment looks like for co-occurring anxiety and depression
Your treatment begins with a clinical evaluation rather than a predetermined protocol.
The Neurotherapeutix team reviews your symptoms, diagnoses, medical and psychiatric history, medications, previous treatments and response to care.
When clinically appropriate, we use computational brain mapping to evaluate your individual functional connectivity and identify potential treatment targets.
Your fMRI findings are then considered alongside your clinical presentation to develop an individualized treatment plan.
During fMRI-guided TMS therapy, magnetic pulses are delivered non-invasively while you remain awake and seated. TMS does not require surgery or anesthesia, and patients generally return to their normal activities after a session.
Your clinical response is monitored throughout treatment. When you have both depression and anxiety symptoms, those symptoms may not change at the same time or to the same degree. Tracking them individually gives your treatment team a clearer picture of how you are responding.
fMRI-guided TMS therapy may also be provided alongside other forms of care, such as psychiatric treatment, medication management or psychotherapy, when clinically appropriate.
Am I a candidate if I have both conditions?
Having both anxiety and depression does not automatically rule you out as a candidate for TMS therapy.
Candidacy depends on your individual clinical circumstances, including your diagnosis, symptoms, treatment history, medical and neurological history, current medications and other safety considerations.
At Neurotherapeutix, we also consider what your functional brain imaging shows before determining how fMRI-guided treatment may fit into your care.
Learn more about TMS therapy candidacy and what our team considers during an evaluation.
Frequently asked questions
For more information about treatment, eligibility, side effects and what to expect, explore our frequently asked questions.
Can one TMS treatment plan address both anxiety and depression?
Potentially. When depression and anxiety symptoms occur together, your clinical team can consider your complete symptom presentation when developing a TMS treatment plan.
This does not necessarily mean one stimulation target independently “treats” two diagnoses.
At Neurotherapeutix, functional brain imaging and computational analysis help determine which individualized treatment targets may be relevant based on your brain connectivity and clinical needs.
Is TMS therapy effective for anxiety that occurs alongside depression?
Research suggests TMS may improve anxiety symptoms in some patients with depression and co-occurring anxiety. However, response varies among individuals, and the evidence and regulatory status of TMS differ by condition and treatment protocol.
Your clinical evaluation can help determine whether fMRI-guided TMS therapy may be appropriate based on your diagnoses, symptoms and treatment history.
Does treating one condition improve the other?
It may, but improvement in one condition does not guarantee improvement in the other.
Anxiety and depression can interact, so changes in one group of symptoms may affect your overall functioning and well-being. However, they remain distinct clinical conditions, and each person responds differently to treatment.
Your treatment team can monitor anxiety and depressive symptoms separately throughout care to understand how each is responding.
How does Neurotherapeutix personalize treatment for comorbid symptoms?
We begin by looking beyond diagnosis alone.
Resting-state fMRI measures communication across functional networks throughout your brain. Our patented computational brain mapping technology analyzes those patterns and helps identify individualized areas of interest that may inform treatment targeting.
Your imaging findings are considered alongside your symptoms, clinical history and previous treatment response to create an individualized plan. Neuronavigation is then used during TMS therapy to consistently locate the selected treatment target.
A treatment plan built around your full symptom picture
When anxiety and depression occur together, you should not have to fit your experience into a one-size-fits-all treatment plan.
Neurotherapeutix is the only clinic in the United States offering our patented fMRI-guided TMS therapy. From our Upper East Side clinic in Manhattan, we combine whole-brain functional imaging, computational analysis and precisely targeted stimulation to personalize treatment based on your individual brain.
If you are living with depression, anxiety or both, our team can help you understand whether fMRI-guided TMS therapy may be appropriate for your needs.
Request an appointment to learn more and get started.
